Alcon to Launch New Cataract Surgery Device
Alcon introduced CE-marked Clareon intraocular lens with an automated delivery system at the European Society of Cataract and Refractive Surgeons Congress in October 2017.
Alcon, global leader in eye care, develops, and manufactures innovative medicines and devices to serve eye care needs. The company recently presented data for the Clareon device as well as studies of other devices. According to the Alcon, Clareon intraocular lens (IOL) is made of advanced optic material, which is delivered through an automated, disposable, and preloaded system. It has been described as a next-generation polymer material that maintains the benefits of Alcon’s AcrySof platform.
“We are proud to deliver on our commitment to bring innovations to the surgical community, and Clareon is one of the biggest breakthroughs in the IOL space,” said Alcon CEO Mike Ball. “This is a great year for Alcon as we celebrate many important milestones—from fulfilling our mission to help people see better by enhancing and transforming the way surgeons treat cataracts through innovations like Clareon, to marking the 100 millionth implant of our flagship AcrySof lenses.”
According to the National Eye Institute, conventionally early cataracts are treated with new eyeglasses, magnifying lenses, and antiglare sunglasses. Cataract surgery involves removal of cataract and implantation of an IOL, which is required when the cataract interferes with a patient’s everyday activity or if the cataract doesn’t allow treatment of a different eye condition.
Novartis is expecting FDA approval for the Clareon, PanOptix trifocal, and trifocal toric lenses by 2019. According to Cataract Surgery Devices Market report published by Coherent Market Insights, although cataract does not interfere the eyesight in the early stages, it interferes with vision and may lead to blindness over the course of time. Cataract surgery is the most commonly performed ophthalmic procedure and it holds a great potential for the growth of cataract surgery devices market. Introduction of new devices in market could offer potential for effective treatment of Cataract.
You may be interested
Gastrointestinal Devices Market Analysis & Outlook 2018-2026 | Top Players are Boston Scientific Corporation, Johnson & Johnson Ltd., Covidien Ltd., Fujinon Ltd., Stryker CorporationAlbert R - November 16, 2018
All bilaterians (animals having a bilateral symmetry) have a GI tract. Primarily, it is a tube that can transfer food to various organs of digestion. In case…
Opioids Market Growth Analysis By Top Players Purdue Pharma L.P., Janssen Pharmaceuticals, Inc., West – Ward Pharmaceuticals Corporation, Pfizer, Inc., Egalet Corporation, Allergan plc, Sanofi SA, Boehringer Ingelheim, and Sun Pharmaceutical Industries Ltd.Albert R - November 16, 2018
According to the American Academy of Pain Medicine (2011), the number of people who suffered from chronic pain was around 1.8 billion. Moreover, according to the NIH…
Bone Cancer Treatment Market Industry Growth Analysis Top Players Amgen Inc., Actavis plc, Novartis International AG, Debiopharm Group, Pfizer, Inc., and Eli Lilly and Company.Albert R - November 16, 2018
The bone cancer treatment market is analyzed on the basis of type of bone cancer into primary bone cancer and secondary bone cancer. Primary bone cancer originates…